{"doi":"10.1002/hep.32517","title":"Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia","abstract":"BACKGROUND AND AIMS: A variant (p.Arg225Trp) of peroxisomal acyl-CoA oxidase 2 (ACOX2), involved in bile acid (BA) side-chain shortening, has been associated with unexplained persistent hypertransaminasemia and accumulation of C27-BAs, mainly 3α,7α,12α-trihydroxy-5β-cholestanoic acid (THCA). We aimed to investigate the prevalence of ACOX2 deficiency-associated hypertransaminasemia (ADAH), its response to ursodeoxycholic acid (UDCA), elucidate its pathophysiological mechanism and identify other inborn errors that could cause this alteration. METHODS AND RESULTS: Among 33 patients with unexplained hypertransaminasemia from 11 hospitals and 13 of their relatives, seven individuals with abnormally high C27-BA levels (>50% of total BAs) were identified by high-performance liquid chromatography-mass spectrometry. The p.Arg225Trp variant was found in homozygosity (exon amplification/sequencing) in two patients and three family members. Two additional nonrelated patients were heterozygous carriers of different alleles: c.673C>T (p.Arg225Trp) and c.456_459del (p.Thr154fs). In patients with ADAH, impaired liver expression of ACOX2, but not ACOX3, was found (immunohistochemistry). Treatment with UDCA normalized aminotransferase levels. Incubation of HuH-7 hepatoma cells with THCA, which was efficiently taken up, but not through BA transporters, increased reactive oxygen species production (flow cytometry), endoplasmic reticulum stress biomarkers (GRP78, CHOP, and XBP1-S/XBP1-U ratio), and BAXα expression (reverse transcription followed by quantitative polymerase chain reaction and immunoblot), whereas cell viability was decreased (tetrazolium salt-based cell viability test). THCA-induced cell toxicity was higher than that of major C24-BAs and was not prevented by UDCA. Fourteen predicted ACOX2 variants were generated (site-directed mutagenesis) and expressed in HuH-7 cells. Functional tests to determine their ability to metabolize THCA identified six with the potential to cause ADAH. CONCLUSIONS: Dysfunctional ACOX2 has been found in several patients with unexplained hypertransaminasemia. This condition can be accurately identified by a noninvasive diagnostic strategy based on plasma BA profiling and ACOX2 sequencing. Moreover, UDCA treatment can efficiently attenuate liver damage in these patients.","journal":"Hepatology","year":2022,"id":254257,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":21,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9595,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":901375,"name":"Ricardo A. Espinosa-Escudero","orcid":null,"position":1,"is_corresponding":false},{"id":702076,"name":"Elisa Herráez","orcid":"0000-0001-9271-3320","position":2,"is_corresponding":false},{"id":900845,"name":"Óscar Briz","orcid":"0000-0001-6891-1554","position":3,"is_corresponding":false},{"id":900846,"name":"María Luisa Cagigal","orcid":"0000-0001-7564-0334","position":4,"is_corresponding":false},{"id":900847,"name":"Jesús M. González‐Santiago","orcid":"0000-0003-4667-4492","position":5,"is_corresponding":false},{"id":900848,"name":"Aida Ortega‐Alonso","orcid":"0000-0002-8999-4093","position":6,"is_corresponding":false},{"id":900849,"name":"Conrado Fernández‐Rodríguez","orcid":"0000-0002-1915-2157","position":7,"is_corresponding":false},{"id":94954,"name":"Luís Bujanda","orcid":"0000-0002-4353-9968","position":8,"is_corresponding":false},{"id":901376,"name":"Marta Calvo Sanchez","orcid":null,"position":9,"is_corresponding":false},{"id":901377,"name":"Delia D ́Avola","orcid":null,"position":10,"is_corresponding":false},{"id":900850,"name":"María‐Carlota Londoño","orcid":"0000-0002-6533-1586","position":11,"is_corresponding":false},{"id":40955,"name":"M. Diago","orcid":"0000-0002-8583-2433","position":12,"is_corresponding":false},{"id":256047,"name":"José C. Fernández‐Checa","orcid":"0000-0003-3422-2990","position":13,"is_corresponding":false},{"id":257278,"name":"Carmen García‐Ruiz","orcid":null,"position":14,"is_corresponding":false},{"id":867196,"name":"Raúl J. Andrade","orcid":"0000-0002-1565-0757","position":15,"is_corresponding":false},{"id":263006,"name":"Frank Lammert","orcid":"0000-0003-4450-7201","position":16,"is_corresponding":false},{"id":802860,"name":"Jesús Prìeto","orcid":"0000-0002-1091-9593","position":17,"is_corresponding":false},{"id":259966,"name":"Javier Crespo","orcid":"0000-0001-8248-0172","position":18,"is_corresponding":false},{"id":900851,"name":"Javier Juampérez","orcid":"0000-0002-8556-6374","position":19,"is_corresponding":false},{"id":900852,"name":"Álvaro Díaz‐González","orcid":"0000-0003-3610-2263","position":20,"is_corresponding":false},{"id":312404,"name":"María J. Monte","orcid":"0000-0003-1844-7428","position":21,"is_corresponding":false},{"id":312405,"name":"José J.G. Marı́n","orcid":"0000-0003-1186-6849","position":22,"is_corresponding":false},{"id":900844,"name":"Marta Alonso‐Peña","orcid":"0000-0003-0934-2202","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":null,"created_at":"2026-07-19T00:25:03.918844Z","pmid":"35395098","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}